Clinical Trials Browser

Completed × Melanoma × tipifarnib × Clear all

NCT00281957 2014-05-20

Sorafenib With Either Temsirolimus or Tipifarnib in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed By Surgery

Phase 2 Completed

109 enrolled 8 charts

Melanoma

NCT00060125 2013-06-05

Tipifarnib in Treating Patients With Metastatic Malignant Melanoma

Phase 2 Completed

Melanoma